Login / Signup

Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery.

Harman S ParharKendall TascheRobert M BrodyGregory S WeinsteinBert W O'MalleyRabie M ShantiJason G Newman
Published in: Head & neck (2020)
While specific evidence regarding SARS-CoV-2 is lacking, PVP-I-based preparations have been successfully demonstrated to reduce viral loads of coronaviruses. They are relatively safe to use in the upper airway and may reduce risk of SARS-CoV-2 aerosolization during upper airway mucosal surgery.
Keyphrases
  • sars cov
  • minimally invasive
  • coronary artery bypass
  • respiratory syndrome coronavirus
  • surgical site infection
  • ulcerative colitis
  • percutaneous coronary intervention
  • atrial fibrillation
  • acute coronary syndrome